Synapse - Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) Meeting Abstract

Authors:	Iyengar, V.; Chicola, J.; Joseph, A.; Okwali, M.; Truong, R.; Bapodra, N.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Kumar, A.; Lue, J. K.; Luttwak, E.; Horwitz, S.; Intlekofer, A. M.; Johnson, W. T.; Moskowitz, A.; Noy, A.; Owens, C.; Palomba, M. L.; Steiner, R. E.; Stuver, R.; Vardhana, S. A.; Zelenetz, A. D.; Salles, G.; Hamlin, P. A.; Torka, P.
Abstract Title:	Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
Meeting Title:	Blood
Journal Title:	Blood
Volume:	144
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2024-11-01
Start Page:	2336
End Page:	2337
Language:	English
ACCESSION:	WOS:001412784500015
DOI:	10.1182/blood-2024-202741
PROVIDER:	wos
Notes:	Meeting Abstract -- 66th Annual Meeting of the American-Society-of-Hematology (ASH) -- DEC 06-09, 2025 -- 1 -- Orlando, FL -- Source: Wos